7 Ways to Repair Your Pancreas and Fix Insulin Resistance for Good

He opens the 7‑step framework by stressing that pancreatic beta cells are vulnerable to oxidative attack, especially in a lipotoxic environment (high‑fat, standard American diet). A PLoS ONE study he cites induced lipotoxicity and hydrogen‑peroxide stress in beta cells and then treated them with rooibos extract. The extract not only preserved beta‑cell function but actively reversed genes that program cell death, in effect turning back the ‘diabetogenic stress’ that accelerates insulin resistance. DeLauer mentions green tea catechins and dark chocolate flavonoids as alternatives but singles out rooibos because of the specific gene‑expression reversal data. The takeaway is that dietary antioxidants are not just general wellness but a tangible weapon against beta‑cell attrition.

He underscores that insulin resistance is fundamentally an inflammatory condition, sometimes misattributed entirely to carbohydrates. The pancreas, like any tissue, suffers when systemic inflammation is high. By referencing the Nutrients meta‑analysis on hospitalized pancreatitis patients, he builds the case that omega‑3’s effects are not trivial—they reduced hard endpoints like death. Extrapolating to daily life, he posits that keeping pancreatic inflammation in check via omega‑3s may break the feedback loop where inflammation impairs insulin secretion, leading to higher glucose, which triggers more inflammation. His personal dose of 2 g DHA+EPA aligns with typical anti‑inflammatory recommendations.

DeLauer acknowledges the ‘woo‑woo’ reputation of ACV but defends it based on its ability to blunt postprandial glucose. He explains that chronic hyperglycemia coupled with large spikes creates a state he calls ‘hypersecretion fatigue’: beta cells work so hard to pump out insulin that they burn out and die—a process known as glucotoxicity. By reducing the amplitude of the glucose peak, ACV gives the pancreas a temporary break. This acute load reduction, he argues, creates a window for the organ to recover, much like deloading an overworked muscle. He emphasizes that this is not a replacement for a low‑glycemic diet but a complementary strategy to ease the burden while other healing takes place.

Building on the ACV point, DeLauer adds that protein and fiber are equally important in modulating the post‑meal glucose curve. He personally uses protein shakes—particularly a plant‑based one with soluble fiber and digestive enzymes—because they reduce the digestive workload on the exocrine pancreas while also blunting the glucose spike. He contrasts whey protein, which is highly insulinogenic and thus might still elicit a sizable insulin release, with a slowly digesting plant protein that releases amino acids gradually. This dual benefit (glucose control + lower digestive enzyme demand) makes the combination a practical, real‑time strategy to give the pancreas a reprieve.

He presents magnesium as a way to ‘stimulate’ insulin production in a beneficial direction, which at first sounds paradoxical. The nuance lies in the beta‑arrestin 2 pathway: when this protein is elevated, it dampens insulin receptor signaling, making cells resistant. Magnesium supplementation, according to the Iranian study he cites, reduces beta‑arrestin 2 gene expression, thereby lifting the brake and allowing insulin to do its job. With cells now more eager to take up glucose, the pancreas can dial back its own insulin output per meal, reducing the wear and tear (‘hypersecretion fatigue’). He recommends staying away from magnesium threonate for metabolic work and instead using malate (which also supports muscle energy) or glycinate (which aids sleep and is well‑absorbed). The pedestrian‑crossing analogy underscores that this effect, while indirect, is critical.

DeLauer ties the earlier exocrine insufficiency data (vitamin deficiencies, osteoporosis) directly to gut health. He argues that a compromised gut barrier allows lipopolysaccharides and other endotoxins into the bloodstream, which stokes chronic inflammation. The pancreas, being highly sensitive, becomes inflamed and begins to fail at both enzyme secretion and insulin handling. To break the cycle, he recommends structural support of the gut lining via collagen and bone broth, fostering a healthy microbiome (which strengthens epithelial tight junctions), and, most passionately, eliminating polysorbates. These emulsifiers, he insists, are used experimentally to lyse cells and cause gut permeability, and they are hidden in many processed foods. He also suggests occasional digestive enzyme supplements when eating large meals to lighten the exocrine demand, but warns against daily reliance because the pancreas might down‑regulate its own enzyme production if it senses exogenous supply.

He brings up ginger as a surprisingly potent tool based on a Bioscience Reports study. In that experiment, diabetic rodents given ginger water showed upregulation of genes linked to the regeneration of pancreatic islet cells—the clusters containing beta, alpha, and delta cells. The result was so profound that they observed actual recovery of beta‑cell mass. While acknowledging the need for more mechanistic human data, DeLauer frames ginger as a low‑cost, antioxidant‑rich addition that aligns with the overall theme of providing the pancreas with the raw materials to heal. He suggests simple habits like ginger tea or adding fresh ginger to water, emphasizing that sometimes the solutions are ‘so silly’ we overlook them.

DeLauer closes with a systemic detox angle. He notes there is no direct way to ‘detox the pancreas,’ but the liver and pancreas are tethered through shared oxidative load. When the liver becomes overwhelmed—from poor diet, alcohol, environmental toxins—it generates reactive oxygen species that can spill into the portal circulation and damage the pancreas. By supplying NAC, the rate‑limiting precursor for glutathione, the liver can mop up these oxidants more efficiently. The 54‑person study he cites is his anchor: significant drops in liver transaminases after NAC indicate the liver is under less duress. With the liver’s ‘fire’ contained, the pancreas is no longer exposed to as much oxidative damage, which otherwise fuels inflammation and beta‑cell dysfunction. He presents NAC as a ‘super important’ indirect lever for pancreatic repair.

DeLauer highlights a study in the journal Pancreas showing that over 80% of people with pancreatitis had measurable digestive‑enzyme insufficiency. Among them, 35% were deficient in vitamin A, 62.5% in vitamin D, and 100% in vitamin E—all fat‑soluble vitamins that need pancreatic lipase for absorption. The same cohort exhibited high rates of osteopenia and osteoporosis because of vitamin D malabsorption. He argues that the root cause is not just the pancreas itself but chronic low‑grade inflammation—often sparked by gut‑barrier dysfunction—that damages the exocrine machinery. By improving gut barrier integrity (collagen, bone broth, microbiome support) and avoiding emulsifiers like polysorbates that disrupt tight junctions, one can lower systemic inflammation and allow the exocrine pancreas to recover, thereby restoring fat digestion and vitamin status.

DeLauer recounts an Iranian study where magnesium supplementation in insulin‑resistant and type‑2 diabetic subjects increased insulin sensitivity, decreased insulin resistance, and up‑regulated genes tied to insulin reception. The mechanism involved a reduction in the expression of a gene called beta‑arrestin 2, which ordinarily dampens insulin signaling. He likens the pathway to a pedestrian cross‑walk button that controls a stoplight: removing the interference (beta‑arrestin 2) allows the insulin signal to flow clearly. By making cells more receptive, the pancreas doesn’t need to pump out as much insulin to get the job done, which could prevent beta‑cell burnout over time. He recommends 400–600 mg of magnesium per day, favoring dimagnesium malate for sustained release or magnesium glycinate for absorption and sleep.

He explains that these same polysorbates are used in laboratory settings to induce intestinal inflammation and increase lipopolysaccharide (LPS) translocation from the gut into the bloodstream. By causing the epithelial tight junctions to loosen, they allow bacterial endotoxins to enter circulation, triggering systemic inflammation that eventually reaches the pancreas. DeLauer states he ‘would die on this hill’ and personally reads labels to eliminate these ingredients. The payoff, he argues, is less gut‑borne inflammation, less spillover oxidative stress on the pancreas, and better conditions for both endocrine and exocrine repair.

DeLauer cites a human trial published in Scientific Reports where 54 people given NAC saw significant drops in ALT, AST, and ALP. Since NAC is the precursor to cysteine—the rate‑limiting step for glutathione production—it ramps up the liver’s master antioxidant. When liver glutathione is adequate, the liver can handle its regular detox workload without passing reactive oxygen species downstream to the pancreas. He frames pancreatic inflammation and poor beta‑cell function as partly a consequence of hepatic overflow, so by boosting glutathione with NAC, you remove one upstream cause of pancreatic decline. No dose was specified in his monologue, but the principle is that daily NAC keeps liver enzymes low and pancreas‑to‑liver oxidative transfer minimal.

He explains that whey protein is highly insulinogenic, which can be useful post‑workout but might over‑stimulate the pancreas if the goal is to reduce hypersecretion fatigue. Conversely, a plant protein like Sun Warrior Active Line, which includes soluble fiber, probiotics, and digestive enzymes, helps blunt the glucose response and requires less enzymatic work from the pancreas. He switches between them depending on whether he wants a fast protein influx or a more gradual, fiber‑accompanied digestion that eases the load on both insulin secretion and exocrine enzyme production. This nuance lets him enjoy the benefits of both without pushing the pancreas into chronic overdrive.